Ortho Evra | Birth-Control Patch
Results of a new study released in February 2006 show
that women using the Ortho Evra birth-control patch
have double the risk of developing blood clots compared
with those who take birth-control pills. Just last
November, the makers of this popular form of birth-control
issued a warning alerting doctors and patients that
women who were using the patch were at greater risk
of developing blood clots that could lead to serious
medical consequences and even death.Side effects associated with the Ortho Evra Patch include:
• DVT (Deep Vein Thrombosis)
• PE (Pulmonary Embolism)
• Blood Clots
• Heart Attack
• Stroke
More than 4 million women have used the Ortho Evra patch since it went on sale in 2002. This birth-control patch works by releasing estrogen directly into the blood stream through vessels near the surface of the skin. Estrogen can promote the formation of blood clots. Blood clots usually form in the legs and sometimes in the lungs. They can travel to the heart or brain, causing heart attacks or strokes which can be deadly.
The Ortho Evra patch exposes users to 60% more estrogen that those using typical birth-control pills. The patch and most birth control-pills contain the same amounts of estrogen, however, women using the patch absorb about 50% more estrogen than those using the pill. This occurs because hormones from the patch get into the bloodstream and are removed from the body differently than those from birth-control pills.
Four months ago the Associated Press reported that Ortho Evra patch users die and suffer blood clots at a much higher rate than women taking the pill. In their investigation the Associated Press found that about a dozen women died in 2004 from blood clots thought to be related to the patch and dozens more suffered strokes and other complications from blood clots.
An internal company memo written by Ortho McNeil, the makers of the Ortho Evra patch, shows the company refused to fund a study comparing its Ortho Evra patch to its Ortho-Cylen pill because of concerns there was "too high a chance that study many not produce positive result for Evra" and that there was a "risk that Othro Evra may be the same or worse than Ortho-Cyclen."
If you or someone you care about has used the Ortho Evra patch and developed blood clots, DVT, PE or experienced a heart attack, stroke or any other serious cardiovascular abnormalities, please fill out our Case Review Contact Form to the right on this page to find out what your case is worth.
Dangerous Drugs
News Articles
Pfizer Starts Media Ad Blitz to Address Smoking Drug Concerns
May 28 (Bloomberg) – Pfizer Inc.
(read more..)
North Carolina Case Claims Financial Calamity From Bayer Drug
5/2/08 - Triangle Business Journal
(read more..)
Panel May Issue Subpoenas Related to FDA Approval
on Antibiotic Drug Ketek
1/28/08 - FDA
(read more..)
Second Safety Warning on Fentanyl Skin Patch
12/21/07 - FDA
(read more..)
F.D.A. Investigates Quit-Smoking Drug
11/20/07 - Associated Press
(read
more..)
Merck to Pay $4.85 Billion To Settle Most Vioxx Cases
11/09/07 - AngelReyesBlog.com
(read
more..)
Cephalon Drug Is Tied to Several Deaths
9/14/07 - The Wall Street Journal
(read
more..)
$5.5 Million Award in First Federal Fentanyl (Duragesic) Pain Patch Trial
6/19/07 - Press Release
(read
more...)